FDA authorizes marketing of diagnostic test that uses novel technology to detect MRSA bacteria - FDA Press Releases

Today, the U.S. Food and Drug Administration authorized marketing of a new diagnostic test based on bacterial viability and novel technology to detect Methicillin-resistant Staphylococcus aureus (MRSA) bacterial colonization, a widespread cause of hospital-acquired infections. The cobas vivoDx MRSA

from FDA Press Releases RSS Feed https://ift.tt/2s2eCGE
via IFTTT